Gyeonggi-do, South Korea

Jae-Sung Hwang


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jae-Sung Hwang: A Pioneer in CETP Inhibitors

Introduction

Jae-Sung Hwang, an accomplished inventor based in Gyeonggi-do, South Korea, has made significant contributions to the field of pharmaceuticals. With a focus on developing innovative compounds, he has a keen interest in addressing health issues related to cholesterol levels and enzyme activity.

Latest Patents

Hwang holds a notable patent for an oxazolidinone derivative recognized as a CETP (cholesteryl ester transfer protein) inhibitor. His patent, titled "Oxazolidinone derivative as CETP inhibitor, its preparation method, and pharmaceutical composition comprising the same," reveals the preparation method of a novel oxazolidinone derivative. This compound exhibits excellent inhibitory activity against CETP and has the potential to be effective in preventing or treating diseases associated with CETP enzyme activity and HDL cholesterol levels, such as dyslipidemia, atherosclerosis, and coronary heart disease.

Career Highlights

Jae-Sung Hwang is associated with Dong-a ST Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work at the company emphasizes not only his dedication to improving healthcare solutions but also his role as a leader in research and development.

Collaborations

Throughout his career, Hwang has collaborated with notable colleagues, including Jang Hyun Park and Seung Hyun Song. These partnerships have enhanced the research efforts within Dong-a ST Co., Ltd. and contributed to the advancement of pharmacological research.

Conclusion

Jae-Sung Hwang's dedication to developing innovative pharmaceutical solutions showcases the potential of his work in addressing critical health issues related to cholesterol and lipid metabolism. His patent on the oxazolidinone derivative stands as a testament to his commitment to advancing medical science and improving patient outcomes. Through his work and collaborations, Hwang continues to play a vital role in the pharmaceutical industry, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…